Back to Trials
NCT06587100Recruiting

Wearable Activity Tracking to Curb Hospitalizations

University of California, San Francisco

Start Date

4/7/2025

Completion Date

12/31/2027

Summary

This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.

Detailed Description

PRIMARY OBJECTIVE: I. Validate a previously developed step-count model for predicting all-cause acute care (pooled across all devices). SECONDARY OBJECTIVES: I. Validate a previously developed model for predicting each ED visits or hospitalizations during external beam RT using continuous step counts before, during, and after treatment. II. Validate the previously developed step-count model for predicting all-cause acute care for each of the two different device platforms. III. Validate concordance of step counts across each of the device's platforms in the Apple group. IV. Validate the previously developed SHIELD-RT Electronic health record (EHR)-based model for predicting unplanned acute care (ED visit or hospitalization). EXPLORATORY OBJECTIVES: I. Refinement of the pre-existing models(step count and SHIELD-RT). II. Evaluate association between wearables collected parameters, EHR-based variables, and acute care events. III. Develop and validate a multi-modal predictive model for predicting acute care. OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups. * GROUP I: Participants receive Fitbit device and undergo non-interventional, standard of care, radiation therapy. * GROUP II: Participants receive Fitbit device and utilize their own personal Apple HealthKit-based device and undergo non-interventional, standard of care, radiation therapy.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age \>= 18. * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2. * Able to understand study procedures and to comply with them for the entire length of the study. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. * Diagnosis of invasive malignancy. * Able to ambulate independently (without the assistance of a cane or walker). * Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement). * Not a previous participant on this protocol for subsequent courses. Exclusion Criteria: * Participants bound to a wheelchair. * Participants unable to ambulate independently (needing assistance of cane or walker).

Interventions

DEVICE

Fitbit

DEVICE

Apple HealthKit-based devices

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm

Locations

University of California, San Francisco

San Francisco, California 94143

United States